Literature DB >> 20032279

Missed insulin boluses for snacks in youth with type 1 diabetes.

Brandon W Vanderwel1, Laurel H Messer, Lauren A Horton, Bryan McNair, Erin C Cobry, Kim K McFann, H Peter Chase.   

Abstract

OBJECTIVE To evaluate the effects of missed insulin boluses for snacks in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS Three months of simultaneous continuous subcutaneous insulin infusion and continuous glucose monitoring data from nine subjects were retrospectively evaluated. Glucose excursions between 1330 and 1700 h were defined as relating to snacks with insulin or snacks with no insulin administered. Area under the curve >180 mg/dl (AUC >180), average Delta glucose, and rate of change were analyzed and compared within and between groups. RESULTS A total of 94 snacks without insulin and 101 snacks with insulin were analyzed. Snacks without insulin had significantly higher log (AUC >180 + 1) (1.26 vs. 0.44 mg/dl per event; P < 0.001), Delta glucose (114 vs. 52 mg/dl; P < 0.001), and average rate of change (1.3 vs. 1.1 mg/dl per minute; P < 0.001). CONCLUSIONS This study shows that afternoon snacks without insulin boluses are common and result in significantly higher glucose excursions than snacks with insulin administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032279      PMCID: PMC2827497          DOI: 10.2337/dc09-1840

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


Previous studies have demonstrated the deleterious effect of missed insulin doses for meals (1–4). None, however, have examined the effect of missed insulin boluses for snacks. Because youth frequently snack when unsupervised, it is likely that missed insulin boluses are even more common for snacks than for meals. The purpose of this investigation was to use data from continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) together to evaluate the glycemic profiles of missed insulin boluses for afternoon snacks.

RESEARCH DESIGN AND METHODS

This is a retrospective (Institutional Review Board approved) analysis of 810 days of CSII and CGM data from nine youth with diabetes. All subjects used the Minimed Paradigm REAL Time System (Northridge, CA) for insulin delivery and CGM. Reports were downloaded using Medtronic CareLink software. Afternoon snacks were identified on CGM as glucose excursions beginning between 1330 and 1700 h. A glucose excursion was considered resolved when glucose levels remained steady for ≥15 min. Glucose excursions with incomplete CGM data or CSII suspension >15 min were discarded. Glucose excursions were identified as a snack with no insulin (SNI) or a snack with insulin (SWI) as described below, and possible snacks not fitting these criteria were excluded from analysis. SNI criteria were as follows: 1) no bolus administered within ±30 min of the beginning of the glucose excursion, 2) increase in glucose level ≥50 mg/dl, 3) average rate of change from baseline to peak of excursion ≥0.8 mg/dl per minute, 4) starting glucose level >80 mg/dl (to exclude treatment of hypoglycemia), and 5) determined not to be the dinner meal. Carbohydrate contents for snacks are not known for SNI. SWI criteria were as follows: 1) bolus administered within ±30 min of the beginning of the glucose excursion, 2) determined not to be the dinner meal, and 3) determined not to be an exclusive correction bolus (confirmed on pump download). Each glucose excursion was characterized by baseline glucose level, peak glucose level, end glucose level, duration of excursion, time spent >180 mg/dl, area under the curve >180 mg/dl (AUC >180), total amplitude of excursion (Δ glucose), average rate of change, and insulin administered. The study's primary outcome was the comparison between the AUC >180 of the glucose excursions for SNI and SWI. Secondary outcomes included comparing the average rate of change and Δ glucose for SNI and SWI. All statistical analysis used Bonferroni's adjusted P values for multiple comparisons. Results are expressed as mean ± 1 SD. Exploratory analyses revealed positive skew in the outcome variables (AUC >180, Δ glucose, and rate of change). Because AUC >180 was used, this resulted in a zero inflated distribution; thus, a two-stage model was used. Generalized estimating equations were used to determine the distribution of events with blood glucose levels ≤180 versus >180 (5) between SNI and SWI. Mixed models were applied by regressing log(AUC>180 + 1.0), log(Δ glucose), and log(rate of change) on to SNI/SWI (unbolused or bolused snack) adjusting for age, sex, and repeated measures on subjects. Results are presented as mean or geometric mean and 95% CI. A general linear mixed-model approach suggested by Cnaan et al. (6) was used to model blood glucose curves.

RESULTS

Data from nine subjects (five female) with a mean A1C of 7.6 ± 0.7%, mean duration of diabetes of 8.6 ± 6.3 years, and a mean age of 15.1 ± 8.8 years were analyzed. Of 195 glucose excursions identified, 94 were classified as SNI and 101 as SWI. Baseline glucose values between SNI and SWI were not significantly different (P = 1.0). A total of 76 of 94 (81.7%) SNI resulted in blood glucose levels >180 compared with 51 of 101 (50.5%), for a resulting OR of 4.80 (95% CI 2.46–9.40) (P < 0.0001 after adjusting for age, sex, and repeated measures among subjects). Mean time spent above 180 mg/dl was 105 ± 89 min for SNI and 34 ± 42 min for SWI. The average glucose excursion for SNI began at 124 ± 47 mg/dl, peaked at 252 ± 65 mg/dl after 100 ± 58 min, and resolved after 175 ± 97 min at 157 ± 59 mg/dl (Fig. 1). The average glucose excursion for SWI began at 130 ± 51 mg/dl, peaked at 191 ± 55 mg/dl after 53 ± 27 min, and resolved after 98 ± 48 min at 145 ± 49 mg/dl. Both the main effects of time and SNI versus SWI were significant (P > 0.0001) as well as the second order effects and interactions concluding that the two curves were significantly different (P < 0.0001). A table of the ratio of covariate effects and confidence intervals is included in the online appendix, which is available at http://care.diabetesjournals.org/cgi/content/full/dc09-1840/DC1.
Figure 1

A comparison of glucose excursions for snacks with insulin (dashed line) and snacks without insulin (solid line).

A comparison of glucose excursions for snacks with insulin (dashed line) and snacks without insulin (solid line). Glucose excursions from SNI had a mean log (AUC >180 + 1) of 1.26 (95% CI 1.06–1.46) compared with 0.44 mg/dl per event (95% CI 0.31–0.57) for SWI (P < 0.001). Neither age nor sex had a significant effect on AUC >180 (P = 1.0 and P = 0.50, respectively). The Δ glucose-adjusted mean for SNI (114 mg/dl [95% CI 101–129]) was significantly different (P < 0.001) from SWI (52 mg/dl [47-59]). Age was not found to have an effect (P = 0.08). The average rate of change was significantly different (P < 0.005) between SNI (1.3 [95% CI 1.2–1.5]) and SWI (1.1 mg/dl/min [1.0–1.2]). Neither age nor sex significantly affected the rate of change (P = 1.0 for both).

CONCLUSIONS

This study shows that when insulin is omitted for afternoon snacks, the area under the curve (>180 mg/dl) is twice that of excursions for bolused snacks. Furthermore, SNI excursions demonstrated a steeper increase in glucose levels and twice the amplitude of SWI excursions. In this study, ∼50% of boluses for snacks (94 of 195) were missed. Diabetes care providers often put much emphasis on mealtime insulin boluses but fail to focus on snacks. Because snacking involves smaller amounts of food over a longer period of time when compared with meals, the glycemic profiles are different. Future prospective studies should include many more subjects, as well as data relating to insulin reduction and food intake with exercise, to further characterize these excursions. Overall, missed insulin boluses for snacks contribute to significant hyperglycemia. Diabetes care providers need to stress the importance of bolusing for snacks as well as for meals.
  5 in total

1.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

Review 2.  Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data.

Authors:  A Cnaan; N M Laird; P Slasor
Journal:  Stat Med       Date:  1997-10-30       Impact factor: 2.373

3.  Memory of insulin pumps and their record as a source of information about insulin therapy in children and adolescents with type 1 diabetes.

Authors:  Ewa Pańkowska; Agata Skórka; Agnieszka Szypowska; Maria Lipka
Journal:  Diabetes Technol Ther       Date:  2005-04       Impact factor: 6.118

4.  Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes.

Authors:  Anna Lindholm Olinder; Anna Kernell; Bibbi Smide
Journal:  Pediatr Diabetes       Date:  2008-10-24       Impact factor: 4.866

5.  Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy.

Authors:  Jonathan Burdick; H Peter Chase; Robert H Slover; Kerry Knievel; Laura Scrimgeour; Aristides K Maniatis; Georgeanna J Klingensmith
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

  5 in total
  15 in total

1.  The use of insulin pumps in youth with type 1 diabetes.

Authors:  David M Maahs; Lauren A Horton; H Peter Chase
Journal:  Diabetes Technol Ther       Date:  2010-06       Impact factor: 6.118

2.  Text Message Intervention for Teens with Type 1 Diabetes Preserves HbA1c: Results of a Randomized Controlled Trial.

Authors:  Dayna E McGill; Lori M Laffel; Lisa K Volkening; Deborah A Butler; Wendy L Levy; Rachel M Wasserman; Barbara J Anderson
Journal:  Diabetes Technol Ther       Date:  2020-05       Impact factor: 6.118

Review 3.  Use of technology when assessing adherence to diabetes self-management behaviors.

Authors:  Kimberly A Driscoll; Deborah Young-Hyman
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

4.  Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

Authors:  H Peter Chase; Francis J Doyle; Howard Zisser; Eric Renard; Revital Nimri; Claudio Cobelli; Bruce A Buckingham; David M Maahs; Stacey Anderson; Lalo Magni; John Lum; Peter Calhoun; Craig Kollman; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2014-09-04       Impact factor: 6.118

5.  Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes.

Authors:  David C Klonoff; Jennifer Y Zhang; Trisha Shang; Chhavi Mehta; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2020-12-08

6.  Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.

Authors:  D Elleri; G Maltoni; J M Allen; M Nodale; K Kumareswaran; L Leelarathna; H Thabit; K Caldwell; M E Wilinska; P Calhoun; C Kollman; D B Dunger; Roman Hovorka
Journal:  Diabetes Obes Metab       Date:  2014-07-06       Impact factor: 6.577

7.  Frequency of mealtime insulin bolus predicts glycated hemoglobin in youths with type 1 diabetes.

Authors:  Susana R Patton; Stephen A DeLurgio; Amanda Fridlington; Cyndy Cohoon; Angela L Turpin; Mark A Clements
Journal:  Diabetes Technol Ther       Date:  2014-04-28       Impact factor: 6.118

8.  Frequency of mealtime insulin bolus as a proxy measure of adherence for children and youths with type 1 diabetes mellitus.

Authors:  Susana R Patton; Mark A Clements; Amanda Fridlington; Cyndy Cohoon; Angela L Turpin; Stephen A Delurgio
Journal:  Diabetes Technol Ther       Date:  2013-01-14       Impact factor: 6.118

9.  Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.

Authors:  Martin Tauschmann; Janet M Allen; Malgorzata E Wilinska; Hood Thabit; Carlo L Acerini; David B Dunger; Roman Hovorka
Journal:  Diabetes Care       Date:  2016-09-09       Impact factor: 19.112

10.  Importance of manually entering blood glucose readings when wireless-compatible meters are not being used with an insulin pump.

Authors:  Kimberly A Driscoll; Suzanne Bennett Johnson; Yuxia Wang; Yuanyuan Tang; Elizabeth C Gill; Adela Mitchell; Nancy Wright; Larry C Deeb
Journal:  J Diabetes Sci Technol       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.